BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7060325)

  • 1. Amiodarone kinetics after oral doses.
    Kannan R; Nademanee K; Hendrickson JA; Rostami HJ; Singh BN
    Clin Pharmacol Ther; 1982 Apr; 31(4):438-44. PubMed ID: 7060325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and body distribution of amiodarone in man.
    Plomp TA; van Rossum JM; Robles de Medina EO; van Lier T; Maes RA
    Arzneimittelforschung; 1984; 34(4):513-20. PubMed ID: 6540111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acceleration of amiodarone elimination by cholestyramine].
    Nitsch J; Lüderitz B
    Dtsch Med Wochenschr; 1986 Aug; 111(33):1241-4. PubMed ID: 3743429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone pharmacokinetics.
    Holt DW; Tucker GT; Jackson PR; Storey GC
    Am Heart J; 1983 Oct; 106(4 Pt 2):840-7. PubMed ID: 6613830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
    Haffajee CI; Love JC; Canada AT; Lesko LJ; Asdourian G; Alpert JS
    Circulation; 1983 Jun; 67(6):1347-55. PubMed ID: 6851030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric identification of amiodarone N-monodesethyl metabolite and application of an HPLC method to a pharmacokinetic study.
    Marchiset D; Aubert C; Sumirtapura YC; Egre A; Cano JP
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):123-8. PubMed ID: 6745303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of amiodarone after intravenous and oral administration.
    Anastasiou-Nana M; Levis GM; Moulopoulos S
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):524-9. PubMed ID: 7174155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of amiodarone in man.
    Riva E; Gerna M; Latini R; Giani P; Volpi A; Maggioni A
    J Cardiovasc Pharmacol; 1982; 4(2):264-9. PubMed ID: 6175810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone and desethylamiodarone elimination kinetics following withdrawal of long-term amiodarone maintenance therapy.
    Marchiset D; Bruno R; Djiane P; Cano JP; Benichou M; Serradimigni A
    Biopharm Drug Dispos; 1985; 6(2):209-15. PubMed ID: 4005397
    [No Abstract]   [Full Text] [Related]  

  • 11. Amiodarone kinetics after single i.v. bolus and multiple dosing in healthy volunteers.
    Riva E; Aarons L; Latini R; Neyroz P; Urso R
    Eur J Clin Pharmacol; 1984; 27(4):491-4. PubMed ID: 6519158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of cardiac and plasma drug levels during long-term amiodarone therapy.
    Debbas NM; Du Cailar C; Sassine A; Derancourt J; Demaille JG; Puech P
    Eur J Clin Invest; 1983 Apr; 13(2):123-7. PubMed ID: 6409635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and myocardial kinetics of amiodarone and its deethyl metabolite after intravenous administration in rabbits.
    Kannan R; Ikeda N; Wagner R; Drachenberg M; Singh BN
    J Pharm Sci; 1984 Sep; 73(9):1208-11. PubMed ID: 6491937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of amiodarone after intravenous and oral administration.
    Andreasen F; Agerbaek H; Bjerregaard P; Gøtzsche H
    Eur J Clin Pharmacol; 1981 Mar; 19(4):293-9. PubMed ID: 7286032
    [No Abstract]   [Full Text] [Related]  

  • 15. Amiodarone: individualizing dosage with serum concentrations.
    Rotmensch HH; Swanson BN; Greenspon AJ; Shoshani D; Greenspan AM
    Pacing Clin Electrophysiol; 1983 Nov; 6(6):1327-35. PubMed ID: 6196742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients.
    Escoubet B; Jaillon P; Berger Y; Commin P; Menasché P; Piwnica A; Echter E
    Am Heart J; 1986 Feb; 111(2):280-5. PubMed ID: 3946169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute bioavailability of amiodarone in normal subjects.
    Pourbaix S; Berger Y; Desager JP; Pacco M; Harvengt C
    Clin Pharmacol Ther; 1985 Feb; 37(2):118-23. PubMed ID: 3967454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial disposition of amiodarone in the dog.
    Latini R; Connolly SJ; Kates RE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):603-8. PubMed ID: 6827483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic evaluation of the digoxin-amiodarone interaction.
    Fenster PE; White NW; Hanson CD
    J Am Coll Cardiol; 1985 Jan; 5(1):108-12. PubMed ID: 3964797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(12):1805-10. PubMed ID: 4096733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.